Biopolym. Cell. 2013; 29(4):348-353.
Development of the system for gene therapy of AIDS on the basis of antisense RNAs
1Shved A. D., 1Kukharenko O. P.
  1. Institute of Molecular Biology and Genetics, NAS of Ukraine
    150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680


Based on adeno-associated virus derived plasmid construct that are able to synthesize in cells antisense RNAs directed against key genes of HIV. Gematopoietic human cells carrying the created structure, acquired resistance to HIV infection, as evidenced by the reduction in infectious titer of HIV in cell culture. The resulting system of intracellular resistance to retrovirus can be seen as a model of gene therapy of AIDS.
Keywords: HIV-AIDS, adeno-associated virus, antisense RNAs, gene therapy, gematopoietic human cells


[1] Baltimore D. Intracellular immunization Nature 1988 335, N 6189:395–396.
[2] Colman A. Antisense strategies in cell and developmental biology J. Cell Sci 1990 97, Pt 3:399–409.
[3] Yu M., Poeschla E., Wong-Staal F. Progress toward gene therapy for HIV infection Gene Ther 1994 1, N 1:13–26.
[4] Shved A. D. Polymicleothle inhibitors of virus reproduction (alkylated nucleic acids, iintiseiisc RNAs and ribozyme) Biopolym. Cell 1998 14, N 4:332–342
[5] Mosca J. D., Ritchey D. W, d'Arcy L. A., Burke D. S., The Henry M. Jackson. Expression of anti-HIV compounds directed from the HIV-LTR: a potential gene therapy for HIV infected individuals 6th Int. AIDS Conf San Francisco, 1990:107.
[6] Muzyczka N. Use of adeno-associated virus as a general transduction vector for mammalian cells Curr. Top. Microbiol. Immunol 1992 158:97–129.
[7] Nahreini P., Woody M. J., Zhou S. Z., Srivastava A. Versatile adeno-associated virus 2-based vectors for constructing recombinant virions Gene 1993 124, N 2:257–262.
[8] Sczakiel G., Oelze I., Rittner K. Microinjection: a technique to study inhibition of HIV-1 replication mediated by antisense RNA and parvovirus genes Biotechnology applications of microinjection, microscopic imaging, and fluorescence. Eds P. H. Bach et al New York: Plenum Press, 1993:1–10.
[9] Antoni B. A., Rabson A. B., Miller I. L., Trempe J. P., Chejanovsky N., Carter B. J. Adeno-associated virus Rep protein inhibits human immunodeficiency virus type 1 production in human cells J. Virol 1991 65, N 1:396–404.
[10] Sczakiel G., Oppenlander M., Rittner K., Pawlita M. Tatand Revdirected antisense RNA expression inhibits and abolishes replication of human immunodeficiency virus type 1: a temporal analysis J. Virol 1992 66, N 9:5576–5581.
[11] Rittner K., Heilbronn R., Kleinschmidt J. A., Sczakiel G. Adeno-associated virus type 2-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) replication: involvement of p78rep/ p68rep and the HIV-1 long terminal repeat J. Gen. Virol 1992 73, Pt 11:2977–2981.
[12] Sullenger B. A., Gallardo H. F., Ungers G. E., Gilboa E. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication Cell 1990 63, N 3 P. 601–608.
[13] Graham G. J., Maio J. J. RNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator Proc. Natl Acad. Sci. USA 1990 87, N 15:5817–5821.
[14] Ivanskaya N. V., Lukash L. L., Shved A. D., Rybalko S. L., Sukhorada O. M., Zherebtsova E. M., Ruban T. O., Podolskaya S. V., Kukcharenko O. P., Grytsak T. F., Maksimenok O. V. Permissivness of human embryo liver cells for HIV infection Biopolym. Cell 1997 13, N 3:245–249